GET THE APP

Neuropharmacology of severe disorders of consciousness due to TBI: From molecular neuroimaging to clinical trials (or the other way around)
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Neuropharmacology of severe disorders of consciousness due to TBI: From molecular neuroimaging to clinical trials (or the other way around)


JOINT EVENT:25th World Congress on CANCER SCIENCE AND THERAPY & 10th World Congress on BIOMARKERS & CLINICAL RESEARCH

October 18-20, 2017 Baltimore, USA

Esteban A Fridman

Weill Cornell Medicine, USA

Posters & Accepted Abstracts: J Cancer Sci Ther

Abstract :

Chronic disorders of consciousness (DOC) produced by very severe structural brain injuries remain a complex and challenging area of study due to the lack of animal models of the disease. Such conditions includes the vegetative state, marked by a wakeful appearance without any signs of behavioral responsiveness, and minimally conscious state, where patients demonstrate limited behavioral evidence of consciousness. Although some patients may retain residual capacities that can be revealed by pharmacological therapies, typically dopaminergic agents, only amantadine has demonstrated some efficacy accelerating the rate of recovery. Since amantadine is a weak dopaminergic drug, my line of research is devoted to better understanding the physiopathology underlying this complex disease by using molecular neuroimaging (i.e., FDG-PET; [11C]raclopride-PET; and MRI). Using this approach, we were able to define a new set of biomarkers suggesting the existence of a presynaptic dopaminergic deficit in severe DOC that could be reversed by introducing the dopamine precursor L-DOPA. In this context, I will propose a new pharmacological model and approach for patients in vegetative state and minimally conscious state in order to facilitate their emergence from unconsciousness, and suggest directions for future research in the extended field of TBI.

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward